Introduction
The purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT;' EC 2.4.2.8) is encoded by an Xlinked gene in humans. Complete deficiency of HPRT causes the Lesch-Nyhan syndrome (1), while partial deficiency ofthis enzyme leads to purine overproduction and gout (2) . Single amino acid substitutions have been identified in four HPRT variants by comparative mapping of tryptic peptides and sequencing of the aberrant peptides (3) . However, most HPRTdeficient subjects have insufficient amounts of mutant protein for this type of analysis. Furthermore, the HPRT gene is very large (44 kb) and Southern blot analyses of genomic DNA from most HPRT-deficient subjects with HPRT cDNA probes are normal (4) . On the other hand, the majority ofHPRT-defi- 1 . Abbreviations used in this paper: HPRT, hypoxanthine-guanine phosphoribosyltransferase.
cient subjects have normal quantities of HPRT mRNA (5) . RNase mapping analysis can be used to detect mutations within mRNA in some mutant subjects (6) . Allele-specific oligonucleotides in conjunction with RNase mapping allow deduction of certain nucleotide substitutions (7) . However, this technique is limited to mutations for which the nucleotide substitution is already known. Therefore, in most cases where sufficient mRNA is present, mutant cDNA cloning currently is the method of choice for defining mutations at the HPRT locus. The amino acid substitution in a fifth variant has been deduced from the nucleotide sequence of a full-length cDNA cloned from a subject with partial HPRT deficiency (8) . These previous studies are summarized in Table I .
In the present study, we have cloned and sequenced a fulllength HPRT cDNA from a patient with the Lesch-Nyhan syndrome. We have identified a single change in codon 71 (QGGC CGC), which predicts an amino acid substitution of arginine for glycine. This HPRT variant, which was previously termed HPRTya1e, is characterized by a normal intracellular concentration of enzyme protein, reduced catalytic activity, and cathodal migration in native PAGE (5) . The altered charge of this mutant enzyme is consistent with the predicted substitution of a neutral amino acid (glycine) by a basic amino acid (arginine). (10) . Poly A' mRNA was purified by oligo-d(T) column chromatography (1 1) . RNase mapping analysis ofthis mRNA was performed as described (6) using human HPRT riboprobes spanning the entire HPRT coding sequence. Both first and second strands of cDNA were synthesized with avian myeloblastosis virus reverse transcriptase according to the method of Polites and Marotti (12) . The double-stranded cDNA was blunt-ended with T4 DNA polymerase and ligated to Eco RI linkers. 
Methods

Materials
Results
Two positive clones were found on screening -260,000 recombinant phage plaques as described in Methods. The sizes of the cDNA inserts from these clones were determined to be 1.4 and 1.0 kb by Southern blot analysis after Eco RI digestion of phage DNA. Both cDNA inserts were subcloned to M13mpl9 and sequenced using synthetic oligomers and the universal primer. The 1.4-kb cDNA, designated pHKT,, was digested with Hae III and then subcloned in M13mpl9 for determination of 3' noncoding sequence. Since RNase mapping analyses of HPRTyaee mRNA using normal HPRT riboprobes spanning the entire coding sequence were normal (data not shown), pHKT, was sequenced in its entirety, and the coding sequence of pHKT, was completed in both directions. It shows a single nucleotide change (G --C) at nucleotide position 211 (Fig. 1) . This G to C change predicts an amino acid substitution from glycine (GGC) to arginine (CGC) in codon 71 (Fig. 2) . Sequencing of the 1.0-kb cDNA clone, which is 138 nucleotides short of the entire coding sequence, also revealed only the same nucleotide change. This nucleotide change does not alter any recognition site for a restriction enzyme within the HPRT gene. The probabilities of f-turn occurrence were calculated for the 11 tetrapeptide combinations ofthe 14 amino acid residues in position 64-77 of normal HPRT (Fig. 3) . The Pt values at residues 68-71 and 69-72 were 2.0 X 10-4 and 0.6 X 10-4, respectively, and the Pt value at residues 70-73 increased from 0.9 X 10-4 to 1.2 X 10-4 (Fig. 3) .
Discussion
We have defined the mutation of a mutant HPRT (HPRTyae) isolated from a patient with the Lesch-Nyhan syndrome. The predominant abnormality in most patients with the LeschNyhan syndrome is reduced concentration of enzyme protein rather than a defect in enzyme function (5) . HPRTyaI1 belongs to the latter class of mutants. In previous studies HPRTy. 1, was shown to have an almost normal concentration of enzyme protein, no detectable catalytic activity, and a cathodal migration in native PAGE (5) . The mutation in HPRTyme should therefore affect catalytic function rather than protein synthesis or degradation. The amino acid substitution predicted in HPRTyIlC is located within a predicted fl-turn region (Fig. 3) . According to the method of Chou and Fasman (16) , replacement of glycine with arginine at residue 71 reduces the probability of fl-turn occurrence at residues 68-72, and elevates its probability at residues 70-73. However, the Pt value at 68-71 in HPRTy.IC was still greater than the arbitrary cut-off value for fl-turn formation. Furthermore, the increment of the pt value at 70-73
in HPRTyalC is small. It has little apparent impact on enzyme protein stability since the intracellular concentration of HPRTyaie is normal. Other secondary structural features such as a-helix or fl-sheet around the mutation site do not appear to be substantially changed by the glycine to arginine substitution. It is not entirely clear ifa change ofprobabilities offl-turn occurrence around the mutation site is sufficient to explain the catalytic dysfunction of HPRTywC.
The substitution of arginine for glycine introduces two additional structural changes. First, arginine has a relatively bulky side chain compared with glycine. Second, a net charge difference occurs. The previously described electrophoretic alteration in HPRTYaIe, cathodal migration during native PAGE (5) , is consistent with the substitution of a neutral amino acid (glycine) by a basic amino acid (arginine). Both of these effects alter the regional microenvironment ofthe protein and probably disrupt normal protein folding. Therefore, this impairment of tertiary structure, as well as the change in net charge, might well affect substrate binding and catalytic activity. This supposition is difficult to evaluate directly due to the absence of residual catalytic activity. Since the three-dimensional tertiary structure of normal human HPRT is not known, the import of structural changes resulting from amino acid substitutions cannot at present be assessed beyond predictions of this sort.
Since most HPRT-deficient subjects have normal levels of mRNA, mutant cDNA cloning is a useful way to identify specific mutations. The marked molecular heterogeneity of human HPRT-deficient states (4-6) thus offers an ideal system for the examination of altered structure-function relationships as well as mutational mechanisms.
